Trial Profile
A 96-week period, cohort study to evaluate whether the telbivudine protects renal function in patients with chronic hepatitis B infection in conjunction with adefovir-based combination therapy
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 17 Dec 2015
Price :
$35
*
At a glance
- Drugs Telbivudine (Primary) ; Adefovir; Entecavir; Lamivudine
- Indications Hepatitis B
- Focus Therapeutic Use
- 17 Dec 2015 New trial record